PCORnet Archive — Page 1 of 1

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
October 14, 2021

STAR Clinical Research Network to receive major grant renewal

Vanderbilt’s STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.

By Bill Snyder
Open bottle labeled “ASPIRIN” lying on its side, with numerous white tablets spilling onto a surface.
May 20, 2021

VUMC is pacesetter for national aspirin study

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

By Paul Govern
Close-up of a high-tech laboratory interface displaying the words “COVID-19” and “VIRUS,” with colorful circuit-like lines and data graphics.
April 19, 2021

VUMC aids national effort to repurpose drugs for COVID-19

Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.

By Bill Snyder
Collage-style group portrait showing a diverse group of adults of varied ages and backgrounds wearing colorful clothing and smiling.
November 17, 2020

A cohort for type 2 diabetes studies

A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.

By Leigh MacMillan
Pregnant person holding several blister packs of white and red pills in front of their abdomen.
January 31, 2019

In utero antibiotics and obesity risk

Maternal antibiotic use during pregnancy was not associated with childhood obesity at age 5, according a national study led by a Vanderbilt pediatrician.

By Leigh MacMillan